Business Standard

India's leading drugmakers stocking up to avoid supply disruptions

Have increased raw material buffer stock by at least 40 days in recent months

drugmakers
Premium

Sohini DasAneesh Phadnis Mumbai
India’s leading drugmakers have increased their raw material buffer stock by at least 40 days in recent months to insulate themselves from global supply disruptions and to not miss any supply opportunity, said sources. 

Multiple sources at the top drugmakers in the country confirmed the average inventory of active pharmaceutical ingredients (APIs), the raw material to make medicine, has gone up to four to five months from an earlier two and a half to three months. 

“We have bought in advance in order to avoid any issues arising out of supply disruptions and price fluctuations. It is an operational decision to keep

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 29 2019 | 11:51 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com